Evofem Biosciences Inc logo

Evofem Biosciences Inc

OTCPK:EVFM (USA)  
$ 0.02 +0.0013 (+9.22%) 10:08 PM EST
At Loss
Market Cap:
$ 707.00K
Enterprise V:
$ 44.02M
Volume:
369.08K
Avg Vol (2M):
1.03M
Volume:
369.08K
At Loss
Avg Vol (2M):
1.03M

Business Description

Description
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. The company's product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -6.3
Debt-to-Equity -0.65
Debt-to-EBITDA -2.7
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -106.78
Distress
Grey
Safe
Beneish M-Score -3.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.44
9-Day RSI 41.11
14-Day RSI 41.96
6-1 Month Momentum % -80.11
12-1 Month Momentum % -99.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.13
Quick Ratio 0.1
Days Inventory 210.23
Days Sales Outstanding 103.33
Days Payable 943.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -672.6
Shareholder Yield % 8398.38

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 64.26
Operating Margin % -97.96
Net Margin % 290.81
FCF Margin % -49.25
ROE % Neg. Equity
ROA % 297.14
ROIC % -29.19
ROC (Joel Greenblatt) % -426.96
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -2.47
EV-to-EBITDA -2.74
EV-to-Revenue 2.42
EV-to-Forward-Revenue 3.22
EV-to-FCF -4.91
Earnings Yield (Greenblatt) % -40.49
FCF Yield % -1267.23

Financials (Next Earnings Date:2024-04-26 Est.)

EVFM's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:EVFM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Evofem Biosciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 18.218
EPS (TTM) ($) -7.738
Beta -1.67
Volatility % 109.64
14-Day RSI 41.96
14-Day ATR ($) 0.003841
20-Day SMA ($) 0.018446
12-1 Month Momentum % -99.55
52-Week Range ($) 0.0122 - 3.875
Shares Outstanding (Mil) 45.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Evofem Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Evofem Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Evofem Biosciences Inc Frequently Asked Questions

What is Evofem Biosciences Inc(EVFM)'s stock price today?
The current price of EVFM is $0.02. The 52 week high of EVFM is $3.88 and 52 week low is $0.01.
When is next earnings date of Evofem Biosciences Inc(EVFM)?
The next earnings date of Evofem Biosciences Inc(EVFM) is 2024-04-26 Est..
Does Evofem Biosciences Inc(EVFM) pay dividends? If so, how much?
Evofem Biosciences Inc(EVFM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1